Loading...
Neuroprotective mechanisms and translational potential of therapeutic hypothermia in the treatment of ischemic stroke
Stroke is a leading cause of disability and death, yet effective treatments for acute stroke has been very limited. Thus far, tissue plasminogen activator has been the only FDA-approved drug for thrombolytic treatment of ischemic stroke patients, yet its application is only applicable to less than 4...
Na minha lista:
| Udgivet i: | Neural Regen Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5399699/ https://ncbi.nlm.nih.gov/pubmed/28469636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.202915 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|